Interacting Drugs |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Deferasirox |
Security Level |
|
Mechanism |
Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased. |
Management |
Monitor therapy |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Deferasirox
Post Review about Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Deferasirox Click here to cancel reply.
Other Interactions of Bacitracin, neomycin, polymyxin B, and hydrocortisone
Other Interactions of Deferasirox
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.